HeartFlow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting
HeartFlow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting
HeartFlow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed
HeartFlow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed
New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway
New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the HeartFlow Analysis is Incorporated into the Diagnostic Pathway
NHS England to Extend Reimbursement for the HeartFlow Analysis through Innovation and Technology Payment (ITP) Program
ITP Program extended in recognition of the positive impact of the HeartFlow Analysis on patient management, streamlining treatment strategies and reducing waiting lists REDWOOD CITY, Calif. – June 5, 2019 – HeartFlow, Inc. today announced that NHS England has extended HeartFlow’s participation in the Innovation and Technology Payment (ITP) program for an additional year. As part of the extension, NHS […]
Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease
Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease
FFRCT RIPCORD Study: Availability of HeartFlow FFRCT Analysis Changes the Management of Patients with Coronary Artery Disease
PARIS — May 19, 2015 — Adding the HeartFlow® FFRCT Analysis to a standard coronary CT angiogram (cCTA) may change the course of treatment in more than one third of patients with coronary artery disease, according to a study presented today at the EuroPCR 2015 conference. Results of the FFRCT RIPCORD study, presented by Prof. Nick Curzen of […]
Late-Breaking Data Reinforces How the HeartFlow Analysis Can Help Physicians Precisely Stratify Heart Disease Patients and Deliver More Personalized Care
Late-Breaking Data Reinforces How the HeartFlow Analysis Can Help Physicians Precisely Stratify Heart Disease Patients and Deliver More Personalized Care
Fast Company Names HeartFlow One of the World’s Most Innovative Companies
Fast Company Names HeartFlow One of the World’s Most Innovative Companies
HeartFlow Survey: Fewer than 1/3 of Americans Know Biggest Health Threat
New Consumer Survey Data Reveals Striking Misconceptions around Heart Health, Medical Anxieties and More REDWOOD CITY, Calif. – February 7, 2019 – HeartFlow, Inc. today announced the findings of a new consumer survey of more than 1,500 adults across the United States that sheds light on dangerous misconceptions and lack of awareness around heart disease, the leading killer […]
New JACC Publication Reinforces Value of a Coronary CTA + HeartFlow Analysis- Guided Pathway for Diagnosing Heart Disease
REDWOOD CITY, Calif. – January 15, 2019 – HeartFlow, Inc. today announced the publication of the PACIFIC substudy showing that the HeartFlow FFRCT Analysis demonstrates the highest diagnostic performance for detecting coronary artery disease (CAD) compared to other non-invasive tests. The HeartFlow Analysis is a non-invasive, personalized cardiac test that starts with a standard coronary computed tomography angiogram (CTA). […]
